Acadian Asset Management’s Lifecore Biomedical LFCR Stock Holding History

Acadian Asset Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,275	Closed	-$49K	–	1730
2018 Q2	$49K	Buy	+3,275	New	+$45.5K	﹤0.01%	1391
2017 Q4	–	Sell	-9,353	Closed	-$121K	–	1633
2017 Q3	$121K	Buy	9,353 +6,504	+228%	+$85.7K	﹤0.01%	984
2017 Q2	$42K	Buy	+2,849	New	+$39.7K	﹤0.01%	1156
2017 Q1	–	Sell	-89,080	Closed	-$1.23M	–	1674
2016 Q4	$1.23M	Buy	89,080 +72,364	+433%	+$1M	0.01%	690
2016 Q3	$224K	Buy	+16,716	New	+$202K	﹤0.01%	946
2015 Q1	–	Sell	-3,050	Closed	-$42K	–	1409
2014 Q4	$42K	Sell	3,050 -25,265	-89%	-$326K	﹤0.01%	1054
2014 Q3	$348K	Buy	+28,315	New	+$353K	﹤0.01%	712
2014 Q1	–	Sell	-12,592	Closed	-$153K	–	1015
2013 Q4	$153K	Sell	12,592 -8,094	-39%	-$96.6K	﹤0.01%	831
2013 Q3	$252K	Buy	+20,686	New	+$289K	﹤0.01%	729

Other funds holding LFCR

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Acadian Asset Management's LFCR Position: Q3 2018 in Review

Acadian Asset Management sold out of Lifecore Biomedical (LFCR) in Q3 2018, closing a stake of 3,275 shares — an estimated $49K sold.

Acadian Asset Management first reported a position in LFCR in Q3 2013 and held it in 9 quarters. The position peaked at $1.23M in Q4 2016. 90 funds tracked by Wall St. Rank hold LFCR as of Q3 2018.

Acadian Asset Management reported no remaining Lifecore Biomedical position as of Q3 2018 after selling out during the quarter.
Acadian Asset Management sold 3,275 Lifecore Biomedical shares in Q3 2018, an estimated $49K.
Acadian Asset Management first reported a position in Lifecore Biomedical in Q3 2013 and held it in 9 quarters.
Acadian Asset Management's Lifecore Biomedical position peaked at $1.23M in Q4 2016.
90 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2018.

Based on Acadian Asset Management's 13F filing for Q3 2018, filed 30 Oct 2018.